U.S. Markets open in 2 hrs 38 mins

Stoke Therapeutics boosts IPO goal by 40 percent

Allison DeAngelis
Stoke Therapeutics boosts IPO goal by 40 percent

Stoke now hopes to raise $123 million when it launches on the Nasdaq market in the coming weeks, according to documents newly filed with the SEC. It originally had filed plans for an $86.25 million initial public offering last month. Stoke could be the fifth Massachusetts biotech to go public this year.